Functions and Success of Oncotaget
Oncotarget was founded in May 2010. The weekly journal is under the leadership of Michael Lisanti. Michael Lisanti is a former editor in chief of the American Journal Pathology. Oncotarget is published weekly. It publishes issues that revolve around oncology. Oncotarget has received an impact factor of 6.63 in the last two years. Oncotarget is a traditionally free access journals. Papers are published on special demand. It publishes most of its papers online. The terms of Oncotarget has several meanings. It encompasses all pathways and molecules in cancer. It also covers cancer cells, neurodegeneration, and microbes.
The success of Oncotarget is as a result of their extended research. They also publish papers beyond oncology. The topics include Neuroscience, cardiology, Pathology, Cell Biology, Endocrinology, and Pharmacology. Oncotarget was ranked among the top in the field of oncology and medicine in 2011. Oncotaget was ranked the highest in the field of Oncology in 2015 and 2016.The primary goal of Oncotarget is to ensure that people live life without diseases. The journal helps all researchers and scientists to contribute to the progress of medicine. Oncortaget has several advantages compared to other pathological magazines. Its benefits include high impact factor and ultra-rapid publication. The advantage of this journal is that it publishes papers that have been rejected by other journals. Acceptance papers appear online. They appear online for two to five days. Submission is often centralized at the Oncotarget submission center. There are clear instructions that are provided by authors. The instructions are labeled in the pathological section. It is very easy to submit a paper in Oncotaget because they provide immediate response.
The mission of Oncotaget is to provide rapid and widely available scientific results. They aim to eliminate the border between all specialties. They wish to link biomedical science and clinical science in order to fight diseases effectively. They allow discoveries to be shared widely in order to reach many people. It is important to note that they also aim to foster the applications of clinical and basic science in order to fight all type of diseases. They maximize their research using insightful peer reviews. Oncotarget has risen rapidly because of constructive and punctual multiple peer reviews. It has become popular because they assist the author in increasing the impact of their research. The journal has uploaded many papers on their Social media website. They are easily accessible.
Doctors who are in different specialties may struggle to be able to connect with each other. This is something that they have been working on for years and it has put somewhat of a hinderance on what doctors are able to do because they are really only able to study different treatment methods in their chosen area of medicine. This is something that has changed over the years and is now something that is going to be different based on the information that Oncotarget has for people. Because of the way that Oncotarget was put together, doctors can make the choice to connect with each other and can learn more about the different things that are going on in other areas of medicine.
It not only allows doctors the chance to branch out in their own field of medicine but to also branch out and find out more information about the other types of medicine available to people.Since Oncotarget was created by an oncologist, it is something that has a primary focus in oncology and different methods for cancer treatment but it has been able to help people who are in other areas of medicine, too. Because of the opportunities that people have when they are studying medicine, Oncotarget has been a great change and has been something that people will be able to benefit from no matter what they are doing.
Oncotarget has been easy for people to try and make all of the right choices and that has given people the chance to learn more about medicine.When the peer review publication was first started, it was something that people could learn about and get more information from. It is now something that even students are able to learn about in the different areas of medicine. No matter what type of doctor a student is studying to be, he or she can get the best experience possible from Oncotarget. They can learn about the different things that can be done to help people who have cancer as well as the different things that can be done for people who have other issues.
Today’s medical research on cancer is sorely lacking; researchers need more data. The data exists in abundance, but clinicians need to combine both genomic and therapeutic data to find working cancer treatments that are applicable to patients. Once this is accomplished, researchers can start working on definitive treatments to combat cancer.
Medications for cancer have varying success rates, and a given drug that may work for one patient doesn’t necessarily work for another. The problem is that researchers are not given all the variables that make up every patient’s physical response, such as other medication, family history and other illnesses. Without this information, clinicians are left with a trial and error approach to treatment.
Eric Lefkovsky, the co-founder and CEO of Tempus, is determined to improve treatment care for cancer patients. Tempus is a platform that collects patient data and allows researchers to use the information. They look for patterns to show how a given treatment affects groups of people. The technology is dedicated to analyzing genomic data in clinical settings in order to improve cancer research treatment effectiveness. Levkofsky started Tempus after his wife was diagnosed with cancer and he saw the need for oncologists to have free access to data.
Levkofsky graduated from the University of Michigan Law School and moved on to become a successful entrepreneur. In addition to Tempus, Lefkovsky is a founding partner of Lightbank, the co-founder and chairman of Groupon and co-founder of Uptake Technologies. He also works for several other technology media based companies.
In 2006, he founded the Lefkovsky Family Foundation with his wife to advance charitable, scientific, medical or educational organizations. Lefkovsky has donated to numerous projects and foundations over the years, but arguably the most notable contributions have been his generous donations to health care and research. He has given over $1,000,000 to different healthcare organizations, including John Hopkins, the Cystic Fibrosis Foundation and the University of Texas MD Anderson Cancer Center.
To know more visit @: lefkofskyfoundation.com/
Nolbilis’ President Harry Fleming said the name change was crucial in order to prevent confusion among companies using ‘Northstar’ in the United States. Nobilis Health Corp partners with physicians in the management and ownership of acute care facilities, ambulatory care facilities, and healthcare services. To date Nobilis Health currently manages and owns five ambulatory surgery centers, three of which are in Houston while there’s a facility located in Dallas and another in Scottsdale, Arizona. In addition to their surgery centers, Nobilis owns an acute care hospital that’s located in Houston.
The facilities owned and managed by Nobilis offer an impressive network of highly skilled and talented board-certified surgeons whom of which are some of the most advanced fellows in the country. Nobilis’ facilities specialize in multiple specialties including podiatry, orthopedic surgery, otolaryngology (which focuses on the ears, nose, and throat), spine surgery, gastrointestinal scopes, pain management, and general surgery. From the beginning of pre-op to the final stages of post-op, the Nobilis Health Corp clinical team is dedicated to providing its patients with care they can trust in while ensuring they receive the best possible experience throughout their treatment. Even the Nobilis nurses, who are trained in life support, display extensive compassion, respect, integrity, accountability, and excellence in the way they interact with patients and their family members on a daily basis.
The entire medical staff and organization at Nobilis Health 100 surgical centers is dedicated to providing the best possible personalized care while exercising an uncompromising commitment to each of their patients using the safest and most effective methods available. They’re known for providing a welcoming, warm and pleasant atmosphere in each and every one of their state-of-the-art facilities which allows most of their patients to return home on the very same day they’ve received their procedure so that they can recuperate and rest in familiar surroundings with family and friends. Each of Nobilis’ facilities are licensed by the state of Texas and are AAAHC (Accreditation Association for Ambulatory Health Care) credited, which shows Nobilis’ commitment and dedication of providing their patients with the highest standard of care and treatment while being recognized as one of the leading health care providers in the United States with an overall patient satisfaction rate of 95%.